Aspen Pharmacare Limited (APNHF)

PNK: APNHF · Real-Time Price · USD

12.24

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

Aspen Pharmacare Income Statement

Financials in ZAR. Fiscal year is July - June.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Jun 30, 2018	Dec 30, 2017	Jun 30, 2017	Dec 30, 2016	Jun 30, 2016	Dec 30, 2015
Revenue	44.25B	42.31B	40.22B	37.93B	38.32B	38.4B	37.73B	38.43B	38.46B	37.93B	38.46B	38.31B	39.76B	41.21B	38.41B	35.6B	35.85B
Cost of Revenue	24.99B	23.21B	21.51B	20.54B	20.69B	21B	20.55B	20.18B	19.83B	19.4B	19.32B	18.63B	19.97B	21.32B	19.51B	17.7B	18.25B
Gross Profit	19.25B	19.1B	18.71B	17.4B	17.63B	17.4B	17.18B	18.25B	18.63B	18.53B	19.14B	19.69B	19.79B	19.9B	18.9B	17.9B	17.6B
Operating Income	7.78B	9.39B	9.39B	8.63B	9.15B	8.78B	8.66B	9.75B	9.77B	9.11B	8.66B	8.51B	8.41B	8.32B	8.66B	9B	8.7B
Interest Income	1.05B	924.55M	523.32M	107.7M	104.24M	145.66M	139.89M	129.39M	155.39M	251.83M	262.94M	182M	220.5M	259M	279.5M	300M	350M
Pretax Income	4.29B	6.11B	6.48B	7.16B	8.07B	7.34B	5.98B	5.4B	5.58B	2.3B	2.67B	6.74B	6.5B	6.25B	6.18B	6.1B	6.3B
Net Income	3.34B	4.82B	5.16B	5.74B	6.44B	5.49B	4.4B	4.4B	4.85B	1.87B	2.19B	6.04B	5.58B	5.13B	4.71B	4.3B	4.75B
Selling & General & Admin	10.03B	9.71B	9.31B	8.77B	8.48B	8.62B	8.52B	8.5B	8.87B	9.41B	7.43B	5.08B	5.3B	5.51B	5.16B	4.8B	6.65B
Research & Development	81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	55.5M	111M	149.5M	188M	194M	200M	200M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	11.56B	9.71B	9.31B	8.77B	8.48B	8.62B	8.52B	8.5B	8.87B	9.41B	9.8B	9.82B	9.98B	10.15B	8.92B	7.7B	8.3B
Interest Expense	1.57B	1.77B	1.14B	575.12M	632.46M	883.8M	1.04B	1.27B	1.43B	1.83B	2.22B	2.16B	2.16B	2.16B	2.08B	2B	2B
Selling & Marketing Expenses	3.33B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.73B	3.47B	3.77B	4.08B	3.74B	3.4B	4.5B
Cost & Expenses	36.76B	32.92B	30.83B	29.31B	29.17B	29.62B	29.07B	28.68B	28.69B	28.82B	29.12B	28.45B	29.96B	31.46B	28.43B	25.4B	26.55B
Income Tax Expense	947.35M	1.29B	1.31B	1.42B	1.63B	1.47B	1.19B	991M	988.19M	717M	735.96M	1.12B	1.12B	1.12B	1.46B	1.8B	1.55B
Shares Outstanding (Basic)	444.12M	444.3M	444.24M	444.2M	450.7M	456.5M	455.16M	456.5M	455.52M	456.5M	455.8M	456.4M	456.4M	456.4M	456.4M	456.4M	456.4M
Shares Outstanding (Diluted)	444.1M	444.3M	444.24M	444.2M	450.7M	456.5M	455.16M	456.5M	455.52M	456.5M	455.8M	456.4M	456.4M	456.4M	456.4M	456.5M	456.5M
EPS (Basic)	7.44	10.70	11.50	12.71	14.13	12.02	9.69	9.75	10.71	4.10	4.78	13.24	12.24	11.24	10.34	9.44	10.42
EPS (Diluted)	7.44	10.70	11.50	12.71	14.13	12.02	9.69	9.75	10.71	4.10	4.78	13.24	12.24	11.24	10.34	9.44	10.42
EBITDA	11.07B	11.25B	11.16B	10.33B	10.85B	10.43B	10.29B	9.67B	8.59B	5.47B	6.16B	10.28B	9.98B	9.68B	10.09B	10.5B	10B
EBIT	2.91B	427.29M	428.69M	468.32M	542.36M	543.47M	485.77M	423.64M	456.43M	292.09M	4.48B	8.91B	8.66B	8.41B	8.25B	8.1B	8.3B
Depreciation & Amortization	1.17B	1.86B	1.77B	1.7B	1.7B	1.65B	1.64B	1.66B	1.57B	1.33B	1.28B	1.37B	1.32B	1.27B	1.23B	1.2B	1.1B